Anafilaxia a Gadobutrol: Uma Complicação Rara ao Contraste de Ressonância Magnética

André Maçães; Duarte Nuno Silva; Ana  Iva Santos; Isabel Rezende

doi:10.20344/amp.23022

Anaphylaxis to Gadobutrol: A Rare Complication of Magnetic Resonance Contrast Media

Authors

André Maçães USF São João do Porto
Duarte Nuno Silva Serviço de Imunoalergologia. Unidade Local de Saúde Santo António. Porto. https://orcid.org/0000-0003-1475-5802
Ana Iva Santos Unidade de Saúde Familiar São João do Porto. Unidade Local de Saúde Santo António. Porto. https://orcid.org/0009-0005-2308-1282
Isabel Rezende Serviço de Imunoalergologia. Unidade Local de Saúde Santo António. Porto. https://orcid.org/0000-0001-7903-1384

DOI:

https://doi.org/10.20344/amp.23022

Keywords:

Anaphylaxis, Contrast Media/adverse effects, Drug Hypersensitivity/diagnosis, Magnetic Resonance Imaging, Organometallic Compounds/adverse effects

Abstract

n/a.

Downloads

Download data is not yet available.

References

Qu H, Li W, Wu Z, Zeng C, Yan H, Fang X, et al. Differences in hypersensitivity reactions and gadolinium deposition disease/symptoms associated with gadolinium exposure to gadolinium-based contrast agents: new insights based on global databases VigiBase, FAERS, and IQVIA-MIDAS. BMC Med. 2024;22:329. DOI: https://doi.org/10.1186/s12916-024-03537-2

Cabrera CM, Clarcast M, Palacios-Cañas A. Clinical validation of the basophil activation test in immediate hypersensitivity reactions to gadolinium-based contrast agents. Int Immunopharmacol. 2023;117:110000. DOI: https://doi.org/10.1016/j.intimp.2023.110000

Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, et al. Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Kidney Med. 2021;3:142-150. DOI: https://doi.org/10.1016/j.xkme.2020.10.001

Jutel M, Agache I, Zemelka-Wiacek M, Akdis M, Chivato T, del Giacco S, et al. Nomenclature of allergic diseases and hypersensitivity reactions: adapted to modern needs: an EAACI position paper. Allergy. 2023;78:2851-74. DOI: https://doi.org/10.1111/all.15889

Gracia Bara MT, Gallardo-Higueras A, Moreno EM, Laffond E, Muñoz Bellido FJ, Martin C, et al. Hypersensitivity to gadolinium-based contrast media. Front Allergy. 2022;3:813927. DOI: https://doi.org/10.3389/falgy.2022.813927

Downloads

PDF (Português)

Published

2025-07-15

How to Cite

Maçães A, Nuno Silva D, Iva Santos A, Rezende I. Anaphylaxis to Gadobutrol: A Rare Complication of Magnetic Resonance Contrast Media. Acta Med Port [Internet]. 2025 Jul. 15 [cited 2025 Dec. 6];38(9):590-1. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/23022

Download Citation

Issue

Vol. 38 No. 9 (2025): September

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.